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 The world is undergoing a dramatic health transition and children are at the forefront. Undernutrition is rapidly shifting to overnutrition.  Although children of developing countries may live to adulthood, they may have an increased risk of early mortality as a result of childhood obesity.  The rapid shift is most pronounced in Latin America, where rates of obesity‐related diseases are already high and continue to climb.    Now, at the first decade of the millennium, undernutrition is waning and fewer children are dying before they reach 5‐years of age (WHO, 2010).  Despite this major stride forward in world health, the pendulum is swiftly swinging to another extreme.  Globally, childhood underweight may be decreasing, but overweight and obesity are on the rise. In the last 5 years, the WHO has doubled its estimation of children less than 5‐years‐old who are overweight or obese from 20 million children in 2005 to over 42 million in 2010 (WHO, 2006; WHO, 2010). The International Obesity Task Force estimates that 10% of children aged five to 17 are either overweight or obese (Lobstein, Baur, Uauy; IASO International Obesity TaskForce, 2004) (see Table 2.1) and most are living in developing countries (WHO, 2010).   Overweight and obesity in childhood is associated with an increased risk of disease and death in adulthood (Daniels, 2006; Gunnell, Frankel, Nanchahal, Peters, & Smith, 1998; Must, Jacques, Dallal, Bajema, & Dietz, 1992; van Dam, Willett, Manson, & Hu, 2006).  The increased risk of mortality from overweight and obesity in childhood lays dormant and becomes apparent after the age of 30, when mortality levels begin to rise (Engeland, Bjorge, Sogaard, & Tverdal, 2003). 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Table 2.1 




  The risk for adult mortality has been shown to begin at thresholds below the standard definitions of childhood overweight and obesity, in the upper ranges of normal weight.  The Harvard Longitudinal Study found increased all‐cause mortality in teenage boys with BMIs greater than the 75th percentile for age (unstandardized curve) (Must et al., 1992).  In a large male and female cohort from Norway, a BMI between the 75th and 84th percentile in childhood, was associated with an increased risk of mortality in middle age compared to those in the 25th to 75th percentile (CDC curve) (Bjorge, Engeland, Tverdal, & Smith, 2008).       The most likely explanation for increased mortality within the upper normal BMI ranges is not that small amounts of childhood fat are “toxic,” but rather that children who are able to gain weight early in life have the tendency to keep gaining.  Epidemiological evidence has found that overweight children, who become normal‐weight adults, do not have an increased risk of early death (Engeland, Bjorge, Tverdal, & Sogaard, 2004).    The probability of reaching a normal weight in adulthood can be estimated with growth charts. Ventura, Loken, & Birch (2009) found that children with BMI values between the 50th and 60th BMI percentile, tend to track (i.e. remain) on that growth trajectory, staying within the normal weight range in adulthood.  In contrast, children with BMI values above the 75th percentile tend to accumulate more fat as they age. The ultimate result is that these children become overweight or obese adults (Guo, Wu, Chumlea, & Roche, 2002; Srinivasan, Bao, Wattigney, & Berenson, 1996; Steinberger, Moran, Hong, Jacobs, & Sinaiko, 2001; Wang, Chyen, Lee, & Lowry, 2008; Whitaker, Wright, Pepe, Seidel, & Dietz, 1997). 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BMI Percentile  Risk Factors   Recommended Evaluation Normal weight (≤85th %ile)  0  BP   1*   BP, Fasting lipids Overweight (>85th – 94th %ile)  < 2**   BP, Fasting lipids   ≥ 2**   BP, Fasting lipids, fasting glucose, AST, ALT  Obese (≥95th %ile)  ≥ 0  BP, Fasting lipids, fasting glucose, AST, ALT (microalbumin/creatinine ratio) Note: Adapted from Barlow & The Expert Committee (2007).  BP – Blood Pressure *  Family Medical History of high cholesterol ** Risk Factors: positive family medical history for weight‐related diseases (obesity, T2DM, cardiovascular disease, hypertension), ethnic minority [African, Hispanic], elevated BP, elevated lipids, tobacco use, and signs of insulin resistance. 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enzymes.            χ2 test      95% CI   Clinical Screen  Sens  Spec  PPV    p‐value    β(exp)  lower  upper  p‐value 






out of 35 (17.1%) had elevated liver enzymes as defined by Krebs et al. (2007).  A closer look at these cases revealed that 5 out of the 6 had two or more risk factors.   ROC curves. ROC analysis was performed on all integral level risk factor variables, as a function of elevated liver enzymes. Variables and area under the curves (AUC) were as follows: BMI (AUC=0.645), BMI Z‐score (AUC=0.637), waist circumference (AUC=0.681), risk factor count (AUC=0.709), systolic blood pressure (AUC=0.708), diastolic blood pressure (AUC=0.612), total cholesterol (AUC=0.431), triglycerides (AUC=0.534), HDL‐C (AUC=0.337).   On the ROC curve, the BMI value that maximized sensitivity (.750) and minimized 1‐specificity (.488) was ≥25.34.  The BMI percentile coordinate that maximized sensitivity (.750) and minimized 1‐specificity (.512) corresponded to ≥ the 75.8th BMI percentile.  Similarly, A WC of 81.5 cm maximized sensitivity (.750) and minimized 1‐specificity (.651).  A systolic pressure of ≥117.5 maximized sensitivity (.688) and 1‐specificity (.298).  When a simple summation of risk factors was set to a ROC curve analysis, having 2 or more risk factors (not including Hispanic ethnicity) had a good sensitivity (.938) and 1‐specificity (.512).   Step 3 Categorical Risk Factors.  After ROC curves were performed with continuous variables, the sensitivity and specificity of individual risk factors was explored (See Table 3.4).     FMHx.  A FMHx of DM was reasonably sensitive (.750) for elevated liver enzymes while a FMHx CVD was specific (.723).  When the variables were combined, having both a FMHx of CVD and DM was not significantly associated with elevated liver enzymes, but having either a FMHx of CVD or DM was significantly 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associated with elevated liver enzymes (p<0.05) on χ2 analysis with a high sensitivity (.938) and low specificity (.298).     Blood Pressure.  A SBP of ≥130 was very specific for elevated liver enzymes (0.915), but not sensitive (0.375). A χ2 test demonstrated a significant relationship between a SBP of ≥130 and elevated liver enzymes (P<0.05).     Dyslipidemia. When individual risk factors were explored through multiple χ2 tests, lipids (total cholesterol, TG, HDL) by the Krebs et al. (2007) definitions failed to correspond significantly with having elevated liver enzymes.   Step 4 Risk Factor Combinations.  Risk factors and the BMI, BMI percentile, and WC cutoffs as recommended by the ROC analysis were combined in multiple ways and tested for significance.  The combination with the highest sensitivity and specificity in Mexican adolescents was the following: elevated blood pressure, with a positive FMHx of either CVD or DM, and a BMI over 25.  If a participant had any 2 out of 3, then it was considered a positive clinical screen and it is recommended to test for liver enzymes. This clinical screen was 0.813 sensitive and 0.740 specific for elevated liver enzymes in this sample. 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Table 3.4 
Exploration of variables as predictors of elevated liver enzymes Variable  AUC  Inflection point*  Sens  1‐sp  Specificity 
Continuous Risk Factors           BMI (kg/m2)    .645  ≥25.34  .750  .488  .512 BMI percentile   .637  75.8th percentile  .750  .512  .488 WC  .681  81.5 cm   .750  .651  .349 Risk Factor count  .709  ≥1.5   .938  .512  .488 SBP   .708  ≥117.5   .688  .298  .702 
Categorical Risk Factors           FMHx T2DM      .750    .447 FMHx CVD      .500    .723 FMHx CVD and/or DM      .938    .298 SBP ≥130      .375    .915            






































  Screen if     
Recommendation  FMHx   or  CVD Risk Factors   Laboratory Test  Citation NCEP‐adult    Screen all patients ≥20‐years‐old  Fasting lipid profile  NCEP, 2002 NCEP‐pediatric  1° with TC≥240            (or) 1° or 2° relative w/      CA bypass surgery      CA angioplasty     CAD, MI, angina,     sudden death     peripheral vasc dz     cerebral vasc dz before age 55 years. 
BMI ≥ 85th %  Fasting lipid profile            (or)  TC if only 1° with TC≥240   
NCEP, 1992 























Variables in the Algorithm   Clinical screening algorithms are meant to guide a physicians’ decision on whether or not to obtain lipids and lipoproteins.  Many algorithms include collecting data in regards to FMHx and identifying patients with additional risk factors such as BMI percentile, elevated blood pressure, and tobacco use.   BMI categories. BMI percentile categories were defined according to Barlow and colleagues (2007). Normal was defined as <85th percentile, overweight as ≥85th percentile but < 95th percentile, and obese as ≥95th percentile using percentile curves published in 2000 by the Centers for Disease Control.  Z‐scores needed to calculate percentile were not available for the 21‐year‐old participants.  In 21‐year‐olds, BMI was used.  BMI categories were defined as normal weight (<25 kg/m2), overweight (25 to 29.9 kg/m2), and obese (≥30.0 kg/m2).   FMHx obesity. Having a family history of obesity in first degree relatives was reported by participants on two questions from the questionnaire. The first question assessed the weight status of the mother and, the second, the father: “Please indicate how you would classify your mother’s (or your father’s) weight currently.” Responses were: markedly underweight, underweight/thin, average weight, overweight, obese, and don’t know.  For this analysis, weight was coded dichotomously (1 if at least one parent was obese and 0 otherwise). “Don’t know” was coded as missing. 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Descriptive statistics by sex Mean and SD  Total  Male  Female  p‐value   Mean  ± SD  Mean  ± SD  Mean  SD  by sex  by age Age  18.43  0.74  18.48  0.79  18.38  0.70  0.055  ‐ Height  1.65  0.09  1.71  0.07  1.59  0.06  0.000  0.344 Birth weight  3.23  0.50  3.26  0.51  3.20  0.49  0.127  0.663 WC (cm)  80.25  11.86  82.94  11.25  78.19  11.91  0.000  0.012 WHtR  0.49  0.07  0.48  0.06  0.49  0.07  0.144  0.028 BMI (kg/m2)  23.77  4.52  23.92  4.30  23.65  4.69  0.386  0.107 SBP (mmHg)  111.24  9.08  114.36  8.95  108.84  8.43  0.000  0.097 glucose (mg/dL)  88.63  8.04  90.68  7.83  87.06  7.86  0.000  0.602                Prevalence (%)             BMI percentile              0.168  0.334 NW  74.4    73.9    74.8       OW  15.9    14.4    17.1       OB  9.7    11.7    8.1       FMHx OB  1.7    1.7    1.7    1.000  0.1 FMHx T2DM  60.4    59.2    61.3    0.566  0.4 FMHx CVD  34.3    30.6    37.1    0.055  0.2 EBP (BP≥130/85)  5.5    9.2    2.8    0.000  0.2 HTN (BP≥140/90)  3.1    5.8    1.1    0.000  0.0 Smoker  6.4    8.9    4.5    0.014  0.0            Clinical Screens for dyslipidemia           NCEP adult  8.8    10.8    7.2    0.080  0 NCEP peds  34.3    30.6    37.1    0.055  0.2 PECR Barlow  25.6    26.1    25.2    0.810  0.3 PECR Krebs  49.8    46.4    52.5    0.093  0.6 SAP  9.7    11.7    8.1    0.097  1.0 AAP  54.0    52.5    55.1    0.482  0.4 AHA  79.2    75.6    82.0    0.025  0.6 Note: p‐value based on ANOVA for continuous variables and Pearson χ2 for categorical variables. AAP – American Association of Pediatrics; AHA – American Heart Association; ANOVA – Analysis of variance; BMI – body mass index; BP – blood pressure; EBP – elevated blood pressure; FMHx OB – Family medical history of obesity in a parent; FMHx T2DM  – Family medical history of diabetes; FMHx CVD – Family medical history of cardiovascular disease;  HTN – hypertension; NCEP – National Cholesterol Education Program; NW – Normal weight (BMI <85th percentile); OW – Overwegiht (BMI 85th to 94.9th percentile); OB – Obesity (BMI ≥ 95th percentile); PECR – Pediatric Expert Committee Recommendations; SAP – Spanish Association of Pediatrics; SBP – Systolic blood pressure; SD – Standard deviation; WC – Waist circumference; WHtR – Waist to height ratio 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 A total of 44.8% of participants had dyslipidemia defined as at least one lipid or lipoprotein abnormality. The most common lipid abnormality was hypertriglyceridemia (TG ≥ 110 mg/dL), which was found in over a third (38.7%) of participants.  The prevalence of HDL‐C ≤40 mg/dL was 24.2%; the prevalence of LDL‐C ≥ 130mg/dl was 12.4%; and the prevalence of total cholesterol ≥ 200mg/dL was 17.9%. There were significant sex differences in TG (P<0.001) and HDL‐C (P<0.001), with males having a higher prevalence of these abnormalities.  No age differences were seen in the prevalence of dyslipidemia or its subcomponents (Table 4.3). Table 4.3 


































































































positive predictive value).            χ2 test      95% CI   Clinical Screen  Sens  Spec  PPV    p‐value    β(exp)  lower  upper  p‐value group a                     PECR screen (no ethnicity)  0.283  0.854  0.059    <0.001    2.21  1.52  3.21  <0.001 Risk Category 1                    0.001 Risk Category 2              0.98  0.62  1.57  0.942 Risk Category 3              1.38  0.76  2.48  0.288 Risk Category 4              2.04  1.10  3.76  0.023 Risk Category 5              2.43  1.53  3.84  <0.001 PECR screen (ethnicity)  0.355  0.798  0.053    <0.001    2.15  1.50  3.06  <0.001 Risk Category 1                    0.001 Risk Category 2              0.96  0.60  1.55  0.865 Risk Category 3              0.87  0.27  2.81  0.813 Risk Category 4              1.78  1.08  2.92  0.024 Risk Category 5              2.48  1.57  3.93  <0.001 group b                     PECR screen (no ethnicity)  0.319  0.820  0.145    0.007    2.16  1.26  3.70  0.005 Risk Category 1                    .076 Risk Category 2              .73  0.36  1.49  .387 Risk Category 3              .96  0.32  2.87  .943 Risk Category 4              1.87  0.87  4.04  .109 Risk Category 5              2.08  1.03  4.21  .042 PECR screen (ethnicity)  0.361  0.774  0.132    0.014    1.96  1.16  3.21  0.011 Risk Category 1                    0.110 Risk Category 2              0.73  0.36  1.49  0.384 Risk Category 3              0.82  0.10  6.63  0.855 Risk Category 4              1.57  0.79  3.13  0.199 Risk Category 5              2.08  1.03  4.21  0.042 CART Analysis                     (1)  0.083  0.981  0.159    <0.001    3.61  2.09  6.23  <0.001 (2)  0.477  0.666  0.056    <0.001    2.33  1.76  3.10  <0.001 (3)  0.363  0.834  0.084    <0.001    2.51  1.87  3.37  <0.001                    Note: Logistic regression with dyslipidemia as a function of the clinical screen controlling for age & sex.  PECR – Pediatric Expert Committee Recommendations CART – classification and regression tree CI – Confidence interval PPV – positive predictive value Sens – Sensitivity Spec – Specificity ** variables: BMIZ, BMI, WC, WHtR, FMHx OB, FMHx DM, FMHx CVD, EBP, HTN, smoker, not sex, age, or risk factor count. Analysis of group b also included the presence of dyslipidemia. 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(P<0.05). On multivariate analysis, the PECR was significantly associated with approximately a 2‐fold increased risk of having IFG (P<0.01) as compared to those with a negative screen. When risk categories were analyzed individually, only Category 5 (P<0.05) was associated with an increased risk of having IFG as compared to Category 1.  This was true when ethnicity was included as risk factor and when it was not. 


































































enzymes, dyslipidemia, and impaired fasting glucose.            χ2 test      95% CI   Clinical Screen  sens  spec  PPV    p‐value    β(exp)  lower  upper  p‐value 
Elevated liver enzymes                     PECR screen (no ethnicity)  0.625   0.787  0.500    0.004    6.17  1.80  21.1  0.004 PECR screen (ethnicity)  0.625  0.660  0.385    0.076    3.23  0.99  10.5  0.051 
Dyslipidemia                     PECR‐Barlow  0.356  0.825  0.623    0.000    2.59  1.88  3.57  0.000 PECR‐Krebs  0.561  0.554  0.504    0.001    1.61  1.22  2.13  0.001 



























Criteria of a valuable screening test.   NALFD  Dyslipid  IFG  The screen must be able to accurately identify a condition of interest.  
 ?   X   X 
The condition of interest is serious   ?  X  X The condition of interest is treatable  X  X  X  The condition of interest has a long latency period   ?  X  X The condition is sufficiently common to justify the cost of screening   X  X   Dyslip – dyslipidemia IFG – impaired fasting glucose NALFD – non alcoholic fatty liver disease X – indicates criteria is met ? – indicated that there is insufficient evidence 
     
 
Future Directions 
  Further research into screening protocols are clearly needed as patterns of disease in Mexico are not identical to those in the United States, where most recommendations originate. Future studies in college applicants should expand the screening protocol to include a diet and physical activity assessment (Barlow et al., 2007). A diet and physical activity assessment may be a good adjunct to the current PECR screening protocol.  There should also be documented follow‐up of those screened.  This is especially important for NALFD, which is an understudied disease entity that affects Hispanics at a disproportionate rate.  Research questions include: 
Does AST and ALT correspond to percent hepatic triglycerides on MRS?  What AST and 
ALT values are reasonable cutoffs for identifying hepatic triglycerides >5% in this 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population?  Is biopsy necessary for staging and treatment?  Regarding blood glucose levels, there is currently insufficient evidence to suggest that early identification of prediabetes affects clinical outcomes (USPTF, 2008). Longitudinal follow‐up of those with IFG, would, therefore, be a valuable addition to the pool of research. Finally, we have explored the PECR screening protocol.  Treatment and follow‐up recommendations were also published in the PECR. These recommendations were not addressed by this study. A future study could be a RCT assigning participants to the PECR treatment arm, and those with standard follow‐up, measuring longitudinal clinical outcomes such as change in BMI and/or disease regression.  Many possibilities exist, but the emphasis should be on improving clinical outcomes for Mexico, while recognizing the limited resources available in this country.  After all, Mexico already suffers a high burden of CVD. As obesity rates in youth continue to rise, more research efforts are needed to avert the incoming tsunami. 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APPENDIX A: 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 The 2009 UP 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its 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supplementary 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